Latest from PubMed

[Magnus1964]

1.

Efficacy in urinary symptom burden, psychological distress, and self-efficacy of education-enhanced interventions in prostate cancer patients: a systematic review and meta-analyses.

Martín-Núñez J, Raya-Benítez J, López-López L, Calvache-Mateo A, Heredia-Ciuró A, Navas-Otero A, Valenza MC.

Support Care Cancer. 2023 May 16;31(6):340. doi: 10.1007/s00520-023-07803-6.

PMID: 37191890 Free PMC article. Review.

2.

Association of soft drinks and 100% fruit juice consumption with risk of cancer: a systematic review and dose-response meta-analysis of prospective cohort studies.

Pan B, Lai H, Ma N, Li D, Deng X, Wang X, Zhang Q, Yang Q, Wang Q, Zhu H, Li M, Cao X, Tian J, Ge L, Yang K.

Int J Behav Nutr Phys Act. 2023 May 15;20(1):58. doi: 10.1186/s12966-023-01459-5.

PMID: 37189146 Free PMC article.

3.

Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up.

Carlsson S, Bock D, Lantz A, Angenete E, Koss Modig K, Hugosson J, Bjartell A, Steineck G, Wiklund P, Haglind E.

Scand J Urol. 2023 May 11;58:11-19. doi: 10.2340/sju.v58.7318.

PMID: 37170656 Clinical Trial.

4.

Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial.

Williams SCR, Mazibuko N, O'Daly O, Zurth C, Patrick F, Kappeler C, Kuss I, Cole PE.

Target Oncol. 2023 May;18(3):403-413. doi: 10.1007/s11523-023-00959-5. Epub 2023 Apr 27.

PMID: 37103658 Free PMC article. Clinical Trial.

5.

Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis.

Zeng H, Dai J, Cao D, Wang M, Zhao J, Zeng Y, Xu N, Xie Y, Liu H, Zeng H, Sun G, Shen P.

Strahlenther Onkol. 2023 Jun;199(6):525-535. doi: 10.1007/s00066-023-02063-z. Epub 2023 Apr 24.

PMID: 37093230 Free PMC article. Review.

6.

Effects and moderators of exercise medicine on cardiometabolic outcomes in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.

Lopez P, Newton RU, Taaffe DR, Winters-Stone K, Buffart LM, Galvão DA.

Crit Rev Oncol Hematol. 2023 Jun;186:103995. doi: 10.1016/j.critrevonc.2023.103995. Epub 2023 Apr 18.

PMID: 37080399 Review.

7.

Cost-effectiveness of different exercise intensities during oncological treatment in the Phys-Can RCT.

Ax AK, Husberg M, Johansson B, Demmelmaier I, Berntsen S, Sjövall K, Börjeson S, Nordin K, Davidson T.

Acta Oncol. 2023 Apr;62(4):414-421. doi: 10.1080/0284186X.2023.2200149. Epub 2023 Apr 19.

PMID: 37074759 Clinical Trial.

8.

Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis.

Li X, Shan L, Wang Q, Zhai H, Xuan Y, Yan G.

Technol Health Care. 2023;31(S1):357-372. doi: 10.3233/THC-236031.

PMID: 37066936 Free PMC article. Review.

9.

Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.

George DJ, Saad F, Cookson MS, Saltzstein DR, Tutrone R, Bossi A, Brown B, Selby B, Lu S, Buckley D, Tombal B, Shore ND.

Clin Genitourin Cancer. 2023 Jun;21(3):383-392.e2. doi: 10.1016/j.clgc.2023.03.009. Epub 2023 Mar 24.

PMID: 37062659 Clinical Trial.

10.

A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.

De La Cerda J, Dunshee C, Gervasi L, Sieber P, Belkoff L, Tutrone R, Lu S, Gatoulis SC, Brown B, Migoya E, Shore N.

Target Oncol. 2023 May;18(3):383-390. doi: 10.1007/s11523-023-00967-5. Epub 2023 Apr 15.

PMID: 37060432 Free PMC article. Clinical Trial.

[maley2711]

that should keep me up all nite!!! especially interested SEs brachy vs IMRT !!!

[Brbnbrn]

Thank you Man!

[Lightjunkie]

Thanks so much!